Artery Embolization vs Operation of Benign Prostate Hyperplasia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
AgeNot listed
SponsorOslo University Hospital

About this trial

Aim of the study is to compare prostate artery embolization (PAE) to the established surgical treatment for patient acceptance, morbidity, complications, and the functional outcomes. To compare length of stay, hospital costs and time for recovery. 140 patients will be randomized to PAE or surgery. Patients should suffer from lower urinary tract symptoms (LUTS), be candidates for both treatments and willing to undergo both procedures. Before randomization computed tomography angiography of the pelvic arteries is done to select eligible patients. Magnetic resonance imaging of prostate rules out possible cancer. The PAE is done in the angio suite in the radiology department injecting small particles into the prostate arteries. The surgery is done in the operation room in the urology department according to established procedures. Clinical follow-up include clinical visit after 3 months, 1 and 5 years. Acute as well as long term complications will be recorded.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

LUTS from Benign Prostate Hyperplasia (BPH) with moderate and severe IPSS score (IPSS > 8) and QoL = or >3

and refractory to medical treatment for at least 6 months or the patient is unwilling to accept medical treatment

or BPH using permanent or intermittent catheterization

Prostate volume > 50 ml

Disqualifiers

Urological disorders: evidence of clinically significant prostate cancer [as defined by START criteria] on prostate biopsy (27,28), prostatitis (29,30), detrusor-sphincter dyssynergia or evidence of neurogenic bladder, urethral strictures, bladder neck contracture, bladder stone or bladder cancer

Renal insufficiency defined as Glomerular Filtration Rate < 30 ml/min/1,73m2

Known severe reactions to iodine-based contrast or gadolinium-based contrast

Previous prostate operation

Trial design

Design model

Parallel

Treatments tested in this trial

  • Prostate operation or prostate artery embolization

    Procedure/Surgery

    As described above.

Treatment groups

140 Participants
are divided into 2 treatment groups
Group A: Prostate operationActive comparator 1 intervention
Group B: Prostate artery embolizationActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Quality of life due to urinary symptoms

"Quality of life due to urinary symptoms" QoL = or \<3 The scale used: Quality of Life Due to Urinary Symptoms. Scale from 0 to 6, the worse is 6. The patient question: If you were to spend the rest of Your life With Your urinary condition just the way it is now, how would you feel about that?

Time frame
3 months
2

Number of patients with Prostate Artery Embolization that did not have prostate operation

The investigators will record the number of patients that did not have prostate surgery after Prostate Artery Embolization. After 3 months the patients will be offered operation when Quality of Life Due to Urinary Symptoms is 4-6 on the scale from 0-6 ie. the patients report unsatisfied (4), unhappy (5) or terrible (6).

Time frame
12 months

Secondary outcomes

1

Number of patients with postoperative complications

Postoperative complications will be recorded according to the Clavien-Dindo classification system. Complication will be recorded during hospital stay, at the follow-up after 3 months and at any intermediate points reported by the patients

Time frame
3 months
2

Hospital stay

Length of stay including before and after the intervention

Time frame
3 months
3

Symptoms

Change in IPSS. The patients fill in the form International Prostate Symptom Score (IPSS) before and after treatment. Seven questions are scored from 0 to 5, 5 is the worst outcome. Total score from 0 - 35. 1-7 is mild symptoms, 8-19 is moderate symptoms, 20-35 is severe symptoms.

Time frame
3 months, 1 year, 5 years

Other outcomes

1

Need for catheters

Number of patients using permanent and intermittent catheters at follow-up will be recorded

Time frame
3 and 12 months
2

Erectile function

Change in erectile function will be recoded using the International Index of Erectile Function (IIEF-5) questionnaire. The patients fill in the form before and after treatment. There are 5 questions which score 1-5, 5 is the best. Total score from 5-25.

Time frame
3 and 12 months
3

Ejaculation

Change in ejaculation will be recorded using the Male Sexual Questionnaire short form for assessing ejaculation. There are 4 questions with 5-6 possible outcomes.

Time frame
3 and 12 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.